Work

Treatment of rheumatoid arthritis with janus kinase inhibitors

Year: 2025

Type: article

Abstract: Rheumatoid arthritis (RA) is a frequent systemic inflammatory polyarthritis. In recent years, considerable knowledge has been gained in the treatment and diagnosis field. This review will address RA in general, focusing on the effect of the newest treatment option: janus kinase (JAK) inhibitors. Furthermore, using JAK inhibitors to treat RA in a Danish context will be discussed. In conclusion, JAK inhibitor treatment is an effective treatment for rheumatoid arthritis - however, potential serious side effects and a high price limit its use.

Source: Ugeskrift for Læger

DOI: 10.61409/v09240651

Authors: Pernille Holme Thorhauge, Anders Løkke Ottesen, Niels Lomborg

Institutions: Vejle Sygehus, Lillebaelt Hospital

Language: Danish

Topic: Rheumatoid Arthritis Research and Therapies

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

OpenAlex ID: W4410242995